Skip to main content

CORRECTION article

Front. Immunol., 24 November 2020
Sec. Inflammation
Volume 11 - 2020 | https://doi.org/10.3389/fimmu.2020.619847

Corrigendum: Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation

This article is a correction to:

  1. Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation

    1. Read original article
Zhe-Kun JiaZhe-Kun Jia1Hai-Yun LiHai-Yun Li2Yu-Lin LiangYu-Lin Liang1Lawrence A. PotempaLawrence A. Potempa3Shang-Rong Ji*Shang-Rong Ji1*Yi Wu,*Yi Wu2,4*
  • 1MOE Key Laboratory of Cell Activities and Stress Adaptations, School of Life Sciences, Lanzhou University, Lanzhou, China
  • 2MOE Key Laboratory of Environment and Genes Related to Diseases, School of Basic Medical Sciences, Xi’an Jiaotong University, Xi’an, China
  • 3Roosevelt University College of Pharmacy, Schaumburg, IL, United States
  • 4The Affiliated Children’s Hospital of Xi’an Jiaotong University, Xi’an, China

A Corrigendum on
Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation

By Jia Z-K, Li H-Y, Liang Y-L, Potempa LA, Ji S-R and Wu Y (2018). Front. Immunol. 9:234. doi: .10.3389/fimmu.2018.00234

In the original article, there was a mistake in Figure 4B as published. The lower panel of Figure 4B was erroneously assigned. The corrected Figure 4B appears below.

FIGURE 4
www.frontiersin.org

Figure 4 mCRP neutralizes the effects of receptor activator of NF-κB ligand (RANKL). Bone marrow-derived macrophages (BMDMs) were treated with 10 ng/mL of M-CSF and 50 ng/ml RANKL in the presence or absence of 100 μg/mL of mCRP. After treatment for 2 days, the expression of TRAP and Cathepsin K were determined by q-PCR (A). After treatment for 6 days, cells were stained for TRAP (B) and counted for the number of osteoclasts (C). Their bone resorption activities were evaluated by toluidine blue staining (D) and the quantification of eroded surface (E). The potent effects of RANKL on BMDMs were absent when treated together with mCRP. Comparable results were also obtained with Raw cells (B–E). *p < 0.05; ***p < 0.001.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: inflammation, rheumatoid arthritis, osteoclast, receptor activator of NF-κB ligand, C-reactive protein

Citation: Jia Z-K, Li H-Y, Liang Y-L, Potempa LA, Ji S-R and Wu Y (2020) Corrigendum: Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation. Front. Immunol. 11:619847. doi: 10.3389/fimmu.2020.619847

Received: 22 October 2020; Accepted: 30 October 2020;
Published: 24 November 2020.

Edited and reviewed by: Mark Slevin, Manchester Metropolitan University, United Kingdom

Copyright © 2020 Jia, Li, Liang, Potempa, Ji and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yi Wu, d3V5QGx6dS5lZHUuY24=; Shang-Rong Ji, anNyQGx6dS5lZHUuY24=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.